A multimedia mosaic of moments at GIST
GIST and Caltech Conduct Joint Researches to Treat Cancers and Parkinson´s Disease - GIST and Caltech select additional two joint research subjects in addition to last year’s four joint research subjects. - One is about inhibiting the growth of cancer cells through micro platforms and the other is reproduction of Parkinson´s Disease via photogenetic technologies.
□ Last year, as the 1st phase of joint research, Gwangju Institute of Science and Technology (GIST, President ž Young Joon Kim) and California Institute of Technology (Caltech) selected four joint research subjects and are carrying out the joint researches. And this year, they selected two additional subjects to enter the 2nd phase of joint research.
□ (Selection of two joint research subjects) Like what had happened during the first phase, nine researchers and professors (including Caltech’s renowned scholars) applied for two joint projects. During last year’s selection processes, 18 professors (including a Nobel laureate in chemistry) applied for four joint research projects.
□ (Subject 1 of the Joint Research Projects) Professor Yang Sung at GIST and Professor James Heath at Caltech carry out joint researches on “development of technologies to inhibit the growth of cancer cells by developing micro platforms”. James Heath was selected as one of the top seven innovators of the world by Forbes in 2009 and ranked 28th of the 100 greatest chemists of the world by Thomson Reuters in 2011.
□ (Subject 2 of the Joint Research Projects) Professor Kim Hyung Ihl at GIST and Professor Viviana Gradinaru at Caltech carry out joint researches on “photogenetic positron tomography for the development and application of the researches into degenerative diseases”.